Our Website Uses Cookies 

We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.

For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Kamakshi Venkataramanan
Kamakshi Venkataramanan
London +44 20 7067 2188 kvenkataramanan@cov.com Download V-card

Kamakshi Venkataramanan is a corporate lawyer from Covington’s London office, who joined the firm as a trainee solicitor in 2013.

Ms. Venkataramanan advises both private and public companies on a broad range of corporate, transactional and advisory matters, including commercial contracts and collaborative ventures, mergers and acquisitions and capital markets transactions. Ms Venkataramanan’s practice has a particular focus on clients in the media & technology and life sciences sectors.

  • Advising Qualcomm Inc. on its £1.56 billion recommended cash offer for CSR plc.
  • Advising Merck & Co. Inc. on several global integrations and restructuring programmes. 
  • Advising Indivior PLC, formerly RB Pharmaceuticals, on its demerger from the Reckitt Benckiser Group.
  • Advising AstraZeneca in its acquisition of Spirogen, a privately held biotech company focused on antibody-drug conjugate technology for use in oncology, for an initial consideration of $200 million and deferred consideration of up to $240 million based on reaching pre-determined development milestones.
  • Advising Vectura Group plc:
    • on its acquisition of German pharmaceutical company Activaero GmbH for a total consideration of €130 million (£108 million); and
    • related fundraising by means of a Placing of shares by Peel Hunt LLP and J.P.Morgan Securities plc to raise approximately £52 million.
  • Advising Horizon Discovery Group plc on its admission of shares to the AIM market on the London Stock Exchange. The IPO raised approximately £40 million before expenses for Horizon and a further £28.6 million for selling shareholders, putting a market capitalisation of company of approximately £120.5 million.
  • Assisting on various commercial matters, including advising global pharmaceutical and technology companies on distributions, collaborations and other commercial ventures, typically involving IP-related issues and transfers of data.

Pro Bono

  • Providing advice to SolarAid, an international charity that combats poverty and climate change.
  • Providing advice to Evidence for Development, a charity dedicated to improving the effectiveness of development aid through economic analysis.   

Previous Experience

  • Previously worked at the in-house legal department of a multinational consumer goods company with a focus on commercial, advertising and consumer goods law.
  • Previously worked in the e-commerce and trade department of a global investment bank.